Cargando…

Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection

Recombinant vaccinia viruses (rVVs) are attenuated viruses and are widely utilized as vectored vaccine platforms against numerous diseases. However, the protective efficacy of these rVV vaccines against Toxoplasma gondii and the resulting mucosal immunity has not been thoroughly assessed. Here, rVVs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Keon-Woong, Chu, Ki-Back, Kang, Hae-Ji, Kim, Min-Ju, Eom, Gi-Deok, Quan, Fu-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878533/ https://www.ncbi.nlm.nih.gov/pubmed/35214611 http://dx.doi.org/10.3390/vaccines10020152

Ejemplares similares

Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021)

Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen
por: Kim, Min-Ju, et al.
Publicado: (2021)

Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection
por: Kim, Min-Ju, et al.
Publicado: (2022)

Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18
por: Yoon, Keon-Woong, et al.
Publicado: (2022)

The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
por: Kang, Hae-Ji, et al.
Publicado: (2023)

Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein
por: Eom, Gi-Deok, et al.
Publicado: (2023)

Expression and Purification of Recombinant ROP1 of Toxoplasma gondii in Bacteria
por: Mohabati, Reyhaneh, et al.
Publicado: (2013)

Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei
por: Kim, Min-Ju, et al.
Publicado: (2022)

The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by Regulating the Active Kinase ROP18
por: Behnke, Michael S., et al.
Publicado: (2012)

Sublingual Vaccination with Live Influenza Virus Induces Better Protection Than Oral Immunization in Mice
por: Mao, Jie, et al.
Publicado: (2022)

Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Recombinant Vaccinia Virus Expressing Plasmodium berghei Apical Membrane Antigen 1 or Microneme Protein Enhances Protection against P. berghei Infection in Mice
por: Kim, Min-Ju, et al.
Publicado: (2022)

The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response
por: Niedelman, Wendy, et al.
Publicado: (2012)

Toxoplasma gondii Superinfection and Virulence during Secondary Infection Correlate with the Exact ROP5/ROP18 Allelic Combination
por: Jensen, Kirk D. C., et al.
Publicado: (2015)

ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii
por: El Hajj, Hiba, et al.
Publicado: (2007)

Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18
por: Molina, Diego, et al.
Publicado: (2018)

Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development
por: Chu, Ki-Back, et al.
Publicado: (2021)

Parasite Infiltration and Apoptosis in Spleen upon Toxoplasma gondii Infection
por: Lee, Su-Hwa, et al.
Publicado: (2019)

ROP18-Mediated Transcriptional Reprogramming of HEK293T Cell Reveals New Roles of ROP18 in the Interplay Between Toxoplasma gondii and the Host Cell
por: Li, Jie-Xi, et al.
Publicado: (2020)

Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice
por: Lee, Dong-Hun, et al.
Publicado: (2019)

Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice
por: Li, Xiu-Zhen, et al.
Publicado: (2015)

Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization
por: Kang, Hae-Ji, et al.
Publicado: (2021)

Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii
por: Zhou, Jian, et al.
Publicado: (2016)

Screening and Identification of the Host Proteins Interacting with Toxoplasma gondii Rhoptry Protein ROP16
por: Pan, Ming, et al.
Publicado: (2017)

Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening
por: Yin, Kun, et al.
Publicado: (2019)

Rhoptry Proteins ROP5 and ROP18 Are Major Murine Virulence Factors in Genetically Divergent South American Strains of Toxoplasma gondii
por: Behnke, Michael S., et al.
Publicado: (2015)

Sequence Variation in Toxoplasma gondii rop17 Gene among Strains from Different Hosts and Geographical Locations
por: Zhang, Nian-Zhang, et al.
Publicado: (2014)

Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection
por: Kang, Hae-Ji, et al.
Publicado: (2018)

The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane
por: Sinai, Anthony P., et al.
Publicado: (2001)

The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading
por: Kim, Elliot W., et al.
Publicado: (2016)

Differential Impacts on Host Transcription by ROP and GRA Effectors from the Intracellular Parasite Toxoplasma gondii
por: Rastogi, Suchita, et al.
Publicado: (2020)

Toxoplasma gondii ROP16(I) Deletion: The Exacerbated Impact on Adverse Pregnant Outcomes in Mice
por: Cui, Wen, et al.
Publicado: (2020)

The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses
por: Chen, Longfei, et al.
Publicado: (2020)

The secreted kinase ROP17 promotes Toxoplasma gondii dissemination by hijacking monocyte tissue migration
por: Drewry, Lisa L, et al.
Publicado: (2019)

ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence
por: Singh, Shishir, et al.
Publicado: (2023)

Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses
por: Lee, Su-Hwa, et al.
Publicado: (2019)

Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice
por: Zhu, Yu-Chao, et al.
Publicado: (2020)

ATF6β is a host cellular target of the Toxoplasma gondii virulence factor ROP18
por: Yamamoto, Masahiro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2h66kli0npc13o3eogp4261506